Business Description
BriaCell Therapeutics Corp
NAICS : 325414
SIC : 3741
ISIN : CA10778Y1043
Share Class Description:
BCTX: Ordinary Shares - NewCompare
Compare
Traded in other countries / regions
BCTX.USABCT.Canada8BT.Germany Description
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -0.66 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 38.9 | |||||
| 3-Year EPS without NRI Growth Rate | 37 | |||||
| 3-Year FCF Growth Rate | 5.7 | |||||
| 3-Year Book Growth Rate | 64.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.24 | |||||
| 9-Day RSI | 25.98 | |||||
| 14-Day RSI | 31.43 | |||||
| 6-1 Month Momentum % | -46.3 | |||||
| 12-1 Month Momentum % | -59.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.99 | |||||
| Quick Ratio | 2.99 | |||||
| Cash Ratio | 1.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -180.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -51.07 | |||||
| ROIC % | -1505.61 | |||||
| ROC (Joel Greenblatt) % | -841.45 | |||||
| ROCE % | -114.04 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.1 | |||||
| EV-to-Forward-EBIT | -0.6 | |||||
| EV-to-EBITDA | -1.1 | |||||
| EV-to-FCF | -0.93 | |||||
| Earnings Yield (Greenblatt) % | -90.91 | |||||
| FCF Yield % | -91.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BCTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BriaCell Therapeutics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.68 | ||
| Beta | 1.53 | ||
| Volatility % | 61.28 | ||
| 14-Day RSI | 31.43 | ||
| 14-Day ATR ($) | 0.243652 | ||
| 20-Day SMA ($) | 2.642885 | ||
| 12-1 Month Momentum % | -59.94 | ||
| 52-Week Range ($) | 2.02 - 7.59 | ||
| Shares Outstanding (Mil) | 15.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BriaCell Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BriaCell Therapeutics Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
BriaCell Therapeutics Corp Frequently Asked Questions
What is BriaCell Therapeutics Corp(BCTX)'s stock price today?
The current price of BCTX is $2.15. The 52 week high of BCTX is $7.59 and 52 week low is $2.02.
When is next earnings date of BriaCell Therapeutics Corp(BCTX)?
The next earnings date of BriaCell Therapeutics Corp(BCTX) is 2024-06-14 Est..
Does BriaCell Therapeutics Corp(BCTX) pay dividends? If so, how much?
BriaCell Therapeutics Corp(BCTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers